Pacira BioSciences, Inc. — Director's Dealing 2013

Jun 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2013-05-30

Reporting Person: EVNIN LUKE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-30	Common Stock	S	44582	$30.00	Disposed	916262	Indirect
2013-05-31	Common Stock	S	9935	$30.00	Disposed	906327	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22746	Direct

Footnotes

F1: This transaction was pursuant to a 10b5-1 Plan.

F2: The shares were sold as follows: 41,782 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 1,610 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 1,190 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC.

F3: Represents the average sales price. The shares were sold between $30.00 and $30.01. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: The shares are held as follows: 858,798 by BV IV QP, 33,089 by BV IV KG and 24,375 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

F5: The shares were sold as follows: 9,311 by BV IV QP, 359 by BV IV KG and 265 by AM BV4.

F6: The shares are held as follows: 849,487 by BV IV QP, 32,730 by BV IV KG and 24,110 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.